cls,trl_lbl,data_lvl,trials,n,m,s,q05,q95
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,agg,237,109293,58.76639992160106,10.785615811087142,40.275001766970725,75.67834241739334
A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,ipd,43,29991,57.187192132010935,11.23868299066923,36.86845451272705,75.06821560835834
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,agg,158,79184,57.91283023164669,10.356179617934853,40.38363145828527,74.26659737974805
A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,ipd,34,28137,59.31373747416614,11.009739748351548,40.01701227778733,76.06795889104069
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,agg,140,44039,61.357848139162385,10.732558889873934,42.91247049201136,78.22346119641571
A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,ipd,32,40191,57.78121392019019,11.17884548230425,36.412194053096925,75.2293439605906
Any,Total trials,agg,489,217321,59.12469981025299,10.688756828791794,40.874372307595834,75.95288422161752
Any,Total trials,ipd,103,92182,58.251460707966835,11.165489036562315,37.582431620374244,75.57129103257911
